Inspire Pharmaceuticals, Inc.

BRYTIMI

pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;

CEMOVION

pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;

CILBI

pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;

CPASS

pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;C PASS;

CWAY

pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;CYSTIC WAY;

CYLRISA

pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;

EVANASE

Pharmaceutical for the treatment of intranasal allergies;

EVANASE

Pharmaceutical preparations for the treatment of cystic fibrosis;

HYCILBI

Pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;

HYCILIA

pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;

IANICCA

Pharmaceutical preparations for lung treatment and the treatment of cystic fibrosis;

INSPIRE

Pharmaceutical preparations for treatment of cardiovascular diseases, and treatment or reduction of pain, including traumatic pain, neuropathic pain, organ pain and/or pain associated with diseases;

INSPIRE

Pharmaceutical preparations for treatment of cardiovascular diseases, and treatment or reduction of pain, including traumatic pain, neuropathic pain, organ pain and/or pain associated with diseases;

INSPIRE

The mark consists of a blue circle with three vertical wavy lines at the end of the black word INSPIRE. The color white is not a feature of the mark and merely indicates a transparent color.;Pharmaceuticals, namely, preparations for treatment of respiratory diseases, lung diseases, eye diseases, mucous membranes, ciliary diseases, and sinus diseases; and nasal aerosols;The color(s) blue and black is/are claimed as a feature of the mark.;